Rockland Immunochemicals specializes in the development and production of high-quality antibodies and reagents that facilitate biomolecule detection, characterization, and analysis. Since its inception in 1962, the company has focused on providing a comprehensive range of products and services, including primary and secondary antibodies, proteins, peptides, and custom antibody production. Notably, Rockland offers unique solutions such as the conversion of monoclonal antibodies to recombinant formats and a specialized panel of reagents for detecting nucleic acid modifications, which operate independently of sequence, format, or location. Their expertise extends to protein and antibody characterization, ensuring that all products meet rigorous quality standards through in-house processes from initial development to final shipment.

In addition to their extensive catalog of antibodies, Rockland provides tailored services for anti-oligonucleotide antibody production, addressing the specific needs of therapeutic and vaccine development programs. Their approach includes a four-phase production process that encompasses antigen preparation, antibody development, purification, and characterization, allowing for the generation of highly specific antibodies against various nucleic acid targets. Furthermore, Rockland's capabilities in host cell protein (HCP) assay development ensure that clients can effectively monitor impurities during bioprocessing, with a focus on delivering robust performance across different assay conditions. This commitment to quality and customization positions Rockland as a valuable partner in advancing life sciences research and development.

United States

Rockland Antibodies is a biotechnology company that offers a wide range of antibodies for academic, biopharma, and diagnostic professionals, catering to various research and development needs.

Rockland Immunochemicals

Company Details